Tower Research Capital LLC (TRC) - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$221
-97.8%
100
-97.3%
0.00%
Q3 2022$10,000
+233.3%
3,768
+184.4%
0.00%
Q2 2022$3,000
-91.4%
1,325
-88.7%
0.00%
Q1 2022$35,000
-37.5%
11,758
-6.8%
0.00%
-100.0%
Q4 2021$56,000
-54.8%
12,615
-50.6%
0.00%
-66.7%
Q3 2021$124,000
-42.9%
25,536
-19.6%
0.00%
-50.0%
Q2 2021$217,000
+274.1%
31,763
+288.1%
0.01%
+500.0%
Q1 2021$58,000
-22.7%
8,184
-30.9%
0.00%
-50.0%
Q4 2020$75,000
-69.1%
11,849
-73.6%
0.00%
-33.3%
Q3 2020$243,000
+556.8%
44,867
+533.6%
0.00%
+50.0%
Q2 2020$37,000
+311.1%
7,081
+225.7%
0.00%
+100.0%
Q2 2019$9,0000.0%2,174
+36.2%
0.00%0.0%
Q1 2019$9,000
-18.2%
1,596
+57.4%
0.00%0.0%
Q2 2018$11,000
-42.1%
1,014
-29.9%
0.00%
-50.0%
Q1 2018$19,000
-76.8%
1,446
-55.6%
0.00%
-71.4%
Q3 2017$82,000
+8100.0%
3,258
+5933.3%
0.01%
Q2 2017$1,000
-50.0%
54
-49.1%
0.00%
Q1 2017$2,000
+100.0%
106
+6.0%
0.00%
Q3 2016$1,000
-95.5%
100
-93.6%
0.00%
-100.0%
Q2 2016$22,000
+214.3%
1,572
+241.0%
0.00%
+100.0%
Q1 2016$7,000
+75.0%
461
+130.5%
0.00%0.0%
Q4 2015$4,000
-86.7%
200
-87.2%
0.00%
-66.7%
Q3 2015$30,000
+233.3%
1,561
+587.7%
0.00%
+200.0%
Q4 2014$9,0002270.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders